Literature DB >> 18266363

Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection.

Jelena M Janjic1, Mangala Srinivas, Deepak K K Kadayakkara, Eric T Ahrens.   

Abstract

We report the design, synthesis, and biological testing of highly stable, nontoxic perfluoropolyether (PFPE) nanoemulsions for dual 19F MRI-fluorescence detection. A linear PFPE polymer was covalently conjugated to common fluorescent dyes (FITC, Alexa647 and BODIPy-TR), mixed with pluronic F68 and linear polyethyleneimine (PEI), and emulsified by microfluidization. Prepared nanoemulsions (<200 nm) were readily taken up by both phagocytic and non-phagocytic cells in vitro after a short (approximately 3 h) co-incubation. Following cell administration in vivo, 19F MRI selectively visualizes cell migration. Exemplary in vivo MRI images are presented of T cells labeled with a dual-mode nanoemulsion in a BALB/c mouse. Fluorescence detection enables fluorescent microscopy and FACS analysis of labeled cells, as demonstrated in several immune cell types including Jurkat cells, primary T cells and dendritic cells. The intracellular fluorescence signal is directly proportional to the 19F NMR signal and can be used to calibrate cell loading in vitro.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266363     DOI: 10.1021/ja077388j

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  89 in total

1.  In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI.

Authors:  Deepak K K Kadayakkara; Jelena M Janjic; Lisa K Pusateri; Won-Bin Young; Eric T Ahrens
Journal:  Magn Reson Med       Date:  2010-09-21       Impact factor: 4.668

2.  19F- and fluorescently labeled micelles as nanoscopic assemblies for chemotherapeutic delivery.

Authors:  Wenjun Du; Zhiqiang Xu; Andreas M Nyström; Ke Zhang; Jeffrey R Leonard; Karen L Wooley
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

3.  Dual-Contrast 19F/1H Magnetic Resonance Imaging to Characterize Myocardial Infarct Healing.

Authors:  Gregory M Lanza
Journal:  Circ Cardiovasc Imaging       Date:  2018-11       Impact factor: 7.792

4.  Amphiphilic hyperbranched fluoropolymers as nanoscopic 19F magnetic resonance imaging agent assemblies.

Authors:  Wenjun Du; Andreas M Nyström; Lei Zhang; Kenya T Powell; Yali Li; Chong Cheng; Samuel A Wickline; Karen L Wooley
Journal:  Biomacromolecules       Date:  2008-09-17       Impact factor: 6.988

5.  Labelling of mammalian cells for visualisation by MRI.

Authors:  Monique R Bernsen; Amber D Moelker; Piotr A Wielopolski; Sandra T van Tiel; Gabriel P Krestin
Journal:  Eur Radiol       Date:  2009-08-12       Impact factor: 5.315

Review 6.  Multimodality imaging probes: design and challenges.

Authors:  Angelique Louie
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

7.  Synthesis and characterization of perfluoro-tert-butyl semifluorinated amphiphilic polymers and their potential application in hydrophobic drug delivery.

Authors:  Sarah Decato; Troy Bemis; Eric Madsen; Sandro Mecozzi
Journal:  Polym Chem       Date:  2014-11-21       Impact factor: 5.582

Review 8.  Liquid perfluorocarbons as contrast agents for ultrasonography and (19)F-MRI.

Authors:  Raquel Díaz-López; Nicolas Tsapis; Elias Fattal
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

9.  Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis.

Authors:  Deepak K Kadayakkara; Pamela L Beatty; Michael S Turner; Jelena M Janjic; Eric T Ahrens; Olivera J Finn
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

10.  Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking.

Authors:  Brooke M Helfer; Anthony Balducci; Aaron D Nelson; Jelena M Janjic; Roberto R Gil; Pawel Kalinski; I Jolanda M de Vries; Eric T Ahrens; Robbie B Mailliard
Journal:  Cytotherapy       Date:  2010-04       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.